1
|
Berhili S, Mouden K, Moukhlissi M, Harroudi TE, Mezouar L. Primary transitional cell carcinoma of the endometrium: Exceptional presentation of a rare tumor. Radiol Case Rep 2023; 18:205-208. [PMCID: PMC9633738 DOI: 10.1016/j.radcr.2022.10.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Revised: 10/05/2022] [Accepted: 10/08/2022] [Indexed: 11/07/2022] Open
Affiliation(s)
- Soufiane Berhili
- Faculty of Medicine, Mohammed Premier University, Oujda, Morocco
- Department of Radiotherapy, Hassan II Oncology Center, CHU Mohammed VI, PK8 Jerada Rd, 60000, Oujda, Morocco
- Corresponding author.
| | - Karima Mouden
- Department of Radiotherapy, Beni Mellal Oncology Center, Beni Mellal, Morocco
| | - Mohammed Moukhlissi
- Faculty of Medicine, Mohammed Premier University, Oujda, Morocco
- Department of Radiotherapy, Hassan II Oncology Center, CHU Mohammed VI, PK8 Jerada Rd, 60000, Oujda, Morocco
| | - Tijani El Harroudi
- Faculty of Medicine, Mohammed Premier University, Oujda, Morocco
- Department of Oncological Surgery, Hassan II Oncology Center, CHU Mohammed VI, Oujda, Morocco
| | - Loubna Mezouar
- Faculty of Medicine, Mohammed Premier University, Oujda, Morocco
- Department of Radiotherapy, Hassan II Oncology Center, CHU Mohammed VI, PK8 Jerada Rd, 60000, Oujda, Morocco
| |
Collapse
|
2
|
Amjad R, Mogharbel H. Primary Transitional Cell Carcinoma of the Endometrium: A Case Report and Review of Literature. Cureus 2022; 14:e21365. [PMID: 35198279 PMCID: PMC8853865 DOI: 10.7759/cureus.21365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/16/2022] [Indexed: 11/09/2022] Open
Abstract
Transitional cell carcinoma of the endometrium is a rare cancer. We present a 58-year-old Caucasian female was diagnosed with high-grade polyploid transitional cell carcinoma of the endometrium. The pathological findings included a dense serosal adhesion over the fundus and the posterior wall, necrotic and polyploid papillary mass in the endometrial cavity, serosal adhesions and unremarkable parenchyma in the fallopian tubes. Others were the presence of cancer antigen 125 and cytokeratin 7 and absence of cytokeratin 20, actin, estrogen receptor, soluble protein 100, vimentin, and cytokeratin high molecular weight. The case is relevant to practice as it identifies the histological patterns for primary transitional cell carcinoma of the endometrium, including expressing cytokeratin 7 instead of cytokeratin 20. The tumor showed a papillary and solid architecture and composed of undifferentiated to poorly differentiated cells with no defined glandular nor squamous differentiation.
Collapse
|
3
|
Transitional cell carcinoma of endometrium: a case report of rare pure form. J Contemp Brachytherapy 2018; 10:483-485. [PMID: 30479627 PMCID: PMC6251443 DOI: 10.5114/jcb.2018.79411] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2018] [Accepted: 10/16/2018] [Indexed: 11/17/2022] Open
Abstract
Transitional cell carcinoma is a very rare histological subtype of endometrial cancer, with only 18 cases described in literature. Ovary represents the most common site where it accounts for 2% of all ovarian cancers. Due to the rarity of this disease, current management is controversial and includes various approaches, mostly described in the adjuvant setting, both radiotherapy and chemotherapy alone or in combination. Here, we report a case of a 65-year-old patient who underwent adjuvant vaginal brachytherapy for an endometrial transitional cell carcinoma. The patient was treated with radical total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH-BSO), without lymph-node sampling, and adjuvant endocavitary brachytherapy delivering 30 Gy in 5 fractions in consecutive days. Treatment tolerance was excellent, with only G1 genitourinary acute toxicity and no other adverse events reported. In this experience, the choice of brachytherapy alone resulted in excellent local control outcomes. However, the patient developed a distant recurrence after 43 months and chemotherapy was applied. More research is required to determine the most effective treatment for this rare histological subtype, and in particular, the role of chemotherapy and radiotherapy combinations.
Collapse
|
4
|
Cubo-Abert M, Rodríguez-Mías NL, Capote S, García-Jiménez A, Sánchez-Iglesias JL, de la Torre J, Gil Moreno A. Advanced Stage of Primary Transitional-Cell Carcinoma of the Endometrium: A Case Report and Literature Review. J Gynecol Surg 2018. [DOI: 10.1089/gyn.2017.0079] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Montserrat Cubo-Abert
- Department of Obstetrics and Gynecology, Hospital Materno–Infantil Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain
| | - Nuria-Laia Rodríguez-Mías
- Department of Obstetrics and Gynecology, Hospital Materno–Infantil Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain
| | - Sira Capote
- Department of Obstetrics and Gynecology, Hospital Materno–Infantil Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain
| | - Angel García-Jiménez
- Department of Pathology, Hospital General Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain
| | - Jose-Luís Sánchez-Iglesias
- Department of Obstetrics and Gynecology, Hospital Materno–Infantil Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain
| | - Javier de la Torre
- Department of Obstetrics and Gynecology, Hospital Materno–Infantil Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain
| | - Antonio Gil Moreno
- Department of Obstetrics and Gynecology, Hospital Materno–Infantil Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain
| |
Collapse
|
5
|
Patrelli TS, Silini EM, Berretta R, Thai E, Gizzo S, Bacchi Modena A, Nardelli GB. Squamotransitional Cell Carcinoma of the Vagina: Diagnosis and Clinical Management. Pathol Oncol Res 2010; 17:149-53. [DOI: 10.1007/s12253-010-9280-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2010] [Accepted: 05/18/2010] [Indexed: 11/24/2022]
|
6
|
Gao Z, Bhuiya T, Falkowski O. Papillary squamotransitional cell carcinoma of the vagina: a case report and review of literature. J OBSTET GYNAECOL 2009; 25:94-6. [PMID: 16147722 DOI: 10.1080/01443610400025804] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Z Gao
- Department of Pathology, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, NY 11040, USA
| | | | | |
Collapse
|
7
|
Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation: a clinicopathologic study of 5 cases and review of the literature. Hum Pathol 2008; 39:1606-13. [DOI: 10.1016/j.humpath.2008.03.005] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2008] [Revised: 03/10/2008] [Accepted: 03/13/2008] [Indexed: 11/18/2022]
|
8
|
Brown L. Pathology of uterine malignancies. Clin Oncol (R Coll Radiol) 2008; 20:433-47. [PMID: 18499412 DOI: 10.1016/j.clon.2008.04.005] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2008] [Accepted: 04/22/2008] [Indexed: 01/17/2023]
Abstract
This overview covers epithelial, stromal and mesenchymal malignancies of the body of the uterus, excluding the cervix. The distinction of type I and type II endometrial adenocarcinoma with the morphological variants of this tumour is discussed and some molecular aspects are explored. The concept of carcinosarcoma representing a metaplastic adenocarcinoma of the endometrium that behaves more like a carcinoma than a sarcoma is explained. Some types of mixed epithelial and stromal neoplasm are described and contrasted with carcinosarcoma. The concept of stromal sarcoma and high-grade uterine sarcoma is described and an outline of malignant smooth muscle tumours of the uterus includes a description of smooth muscle tumours of uncertain malignant potential and worrying benign smooth muscle lesions.
Collapse
Affiliation(s)
- L Brown
- Department of Histopathology, Leicester Royal Infirmary, Infirmary Square, Leicester, UK.
| |
Collapse
|
9
|
Giordano G, Azzoni C, D'Adda T, Merisio C. P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas. Pathol Res Pract 2007; 203:533-8. [PMID: 17498885 DOI: 10.1016/j.prp.2007.03.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/24/2007] [Accepted: 03/12/2007] [Indexed: 11/19/2022]
Abstract
In the current study, we evaluated p16 expression in rare subtypes of endometrial carcinomas, whose HPV status has been previously examined in order to establish the role of this protein in their pathogenesis. These rare subtypes of endometrial carcinomas are primary squamous endometrial carcinoma (ESCC), endometrial mucinous microglandular adenocarcinoma (EMMA), and endometrial transitional cell carcinoma (ETCC). All tissues, obtained at the time of hysterectomy, were fixed in 10% phosphate-buffered formalin and embedded in paraffin. Serial sections were made for hematoxylin and eosin staining and for immunohistochemistry. Although a previous PCR study has demonstrated that none of these neoplasms showed any signal for HPV DNA, these malignancies did display immunoreactivity for P16(INK4a). In ESCC, P16(INK4a) immunoreactivity was diffuse in 100% of neoplastic cells. In two cases of EMMA, positivity for P16INK4a was zonal. In ETCC, scattered cells were positive for P16INK4a protein. These findings suggest that alteration of p16 could play an etiologic role, without any association to HPV infections, in these rare endometrial carcinomas. However, in our view, other cases of these rare malignancies should be investigated in order to confirm this hypothesis.
Collapse
Affiliation(s)
- Giovanna Giordano
- Department of Pathology and Laboratory Medicine, Section of Pathology, Parma University, Viale A. Gramsci, 14, 43100 Parma, Italy.
| | | | | | | |
Collapse
|
10
|
Ribeiro-Silva A. Immunohistochemical features of a papillary squamous cell carcinoma of the endometrium with transitional cell differentiation. Diagn Pathol 2007; 2:26. [PMID: 17645802 PMCID: PMC1947947 DOI: 10.1186/1746-1596-2-26] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2007] [Accepted: 07/23/2007] [Indexed: 11/10/2022] Open
Abstract
An 84-year-old woman underwent hysterectomy due to a friable endometrial mass infiltrating almost half way through the myometrial wall. The tumor consisted of papillary structures with thin fibrovascular cores covered by several layers of pleomorphic cells. The deeply located neoplastic cells were ovoid with a pale eosinophilic cytoplasm resembling urothelial cells. A diagnosis of papillary squamous cell carcinoma of the endometrium with transitional cell differentiation was made. Although she recovered well after surgery, she died one year later because of disseminated disease. In an attempt to obtain new insights into the physiopathology of this very rare tumor, an immunohistochemical panel with 32 markers was performed. The neoplastic cells were positive for cytokeratin 5, vimentin, p63, p21, VEGF, Ki67, BAG1, and bcl-2. The expression of BAG-1 and bcl-2 may suggest that anti-apoptotic stimuli are preponderant in this neoplasm.
Collapse
Affiliation(s)
- Alfredo Ribeiro-Silva
- Department of Pathology, Ribeirão Preto Medical School, University of São Paulo, Brazil.
| |
Collapse
|
11
|
Giordano G, D'Adda T, Gnetti L, Merisio C, Raboni S. Transitional Cell Carcinoma of the Endometrium Associated With Benign Ovarian Brenner Tumor. Int J Gynecol Pathol 2007; 26:298-304. [PMID: 17581415 DOI: 10.1097/01.pgp.0000236943.28969.b2] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Transitional cell carcinoma of the endometrium (TCCE) is a subtype of endometrial carcinoma, characterized by a prominent papillary pattern, resembling the papillary carcinoma of the urothelium. This neoplasm is very rare, with only 13 cases reported in the international literature. In this paper, a new case of TCCE associated with benign ovarian Brenner tumor is described. This association is extremely rare, with only 1 other case reported. A review of the literature is performed to delineate the clinico pathologic features of this malignancy. Moreover, immunohistochemical and molecular studies are carried out in the effort to establish the phenotype and etiology of this rare neoplasm. The molecular study, by polymerase chain reaction (PCR) failing to reveal the presence of HPV DNA, demonstrates that neither the TCCE nor the ovarian Brenner tumor is caused by an HPV infection. The association of TCCE with benign ovarian Brenner tumor could be a coincidental event. Conversely, this finding could be the manifestation of a multicentric metaplastic process (neometaplasia), involving both the coelomic epithelium of the ovary and the Mullerian epithelium of the uterus, or the evidence of "field effect" that manifests differently at different anatomical sites. In our view, other cases of TCCE associated with ovarian Brenner tumor should be reported to confirm the last 2 hypotheses.
Collapse
Affiliation(s)
- Giovanna Giordano
- Department of Pathology and Medicine of Laboratory, Section of Pathology, Parma University, Parma, Italy.
| | | | | | | | | |
Collapse
|
12
|
Abstract
We report a case of primary transitional cell carcinoma of the endometrium and review the literature which reveals only 12 cases described to date. The patient presented with postmenopausal bleeding, and there were no distinctive clinical features. An endometrial sample taken at hysteroscopy was reported as a poorly differentiated, papillary, nonserous carcinoma with probable squamous metaplasia. The tumor removed at hysterectomy and bilateral salpingo-oophorectomy was almost all transitional cell with small areas of endometrioid, glandular differentiation. Immunohistochemistry demonstrated a similar immunoprofile to endometrioid carcinoma of the endometrium and different from reported cases of transitional cell carcinoma of the ovary and of the urinary tract.
Collapse
Affiliation(s)
- Monica Ahluwalia
- Department of Cellular Pathology, Good Hope Hospital, Sutton Coldfield, West Midlands, B75 7RR, UK
| | | | | | | |
Collapse
|
13
|
|
14
|
Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2004; 11:117-42. [PMID: 15096727 DOI: 10.1097/00125480-200405000-00001] [Citation(s) in RCA: 86] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
This review considers the clinical and pathologic features of the various histologic subtypes of endometrial carcinoma excluding those of pure endometrioid type, as the latter tumors were the subject of a previous contribution in the Journal (Vol. 9, No. 2). Non-endometrioid carcinomas, which account for about 10% of endometrial carcinomas, may pose a great array of problems in differential diagnosis, including their distinction not only from benign lesions but also endometrioid carcinoma and various tumors that may secondarily involve the uterine corpus. The most common subtypes are serous, mucinous, and undifferentiated. Rarer tumors are clear cell, squamous, transitional cell carcinomas, and a variety of poorly differentiated carcinomas with unusual forms of differentiation, such as hepatoid carcinoma, carcinomas with trophoblastic elements, and giant cell carcinoma. Mixed carcinomas, which are common, are also discussed, including those with a component of endometrioid carcinoma. The final section deals with endometrial involvement by metastatic tumors, lesions that, albeit rare, are sometimes neglected in the differential diagnosis of endometrial carcinomas. Important aspects emphasized are: (1) The potential for serous carcinoma to be mimicked by various forms of papillary endometrioid carcinoma. (2) The rarity of clear cell carcinoma and the greater frequency of clear cells in endometrioid carcinoma. (3) The frequency of mucinous epithelium in tumors of mixed cell type. (4) The frequency with which neoplastic mucinous epithelium originates from the endometrium. (5) The striking degree of differentiation of some squamous cell carcinomas. (6) The occasional predominance of non-endometrioid carcinomas (especially serous or undifferentiated carcinoma) within malignant mullerian mixed tumors. (7) The spectrum of reactive epithelial changes and other non-neoplastic abnormalities that may mimic serous or clear cell carcinoma.
Collapse
Affiliation(s)
- Philip B Clement
- Department of Pathology, Vancouver General Hospital and Health Science Centre and the University of Columbia, Vancouver, British Columbia, Canada.
| | | |
Collapse
|